Announce Date | 11/06/2024 |
EPS Normalized Actual | $0.2 (Beat by $0.06) |
EPS GAAP Actual | $0.2 (Beat by $0.06) |
Revenue Actual | $0.115468B |
Revenue Surprise | Beat by $115.468M |
Announce Date | 10/01/2024 (Pre-Market) |
EPS Normalized Estimate | $0.18378 |
EPS GAAP Estimate | $0.18378 |
Revenue Estimate | $0.249959558B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2028 | 2.99826 | 5.25 | 2.77468 | 3.20134 | 7 |
Dec 2027 | 2.38844 | 6.59 | 2.21033 | 2.55022 | 6 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2022 (Mar 2022) | -0.7 | -0.7 | 0.115468B | 7.72% | 115.47M |
FQ4 2021 (Dec 2021) | -0.27 | -0.27 | 0.130758B | 7.46% | 130.76M |
FQ3 2021 (Sep 2021) | -0.09 | -0.09 | 0.131612B | 8.38% | 131.61M |
FQ2 2021 (Jun 2021) | -0.27 | -0.27 | 0.115221B | 4.44% | 115.22M |
FQ1 2021 (Mar 2021) | -0.42 | -0.42 | 0.106554B | 15.47% | 106.55M |
FQ4 2020 (Dec 2020) | -0.42 | -0.42 | 0.121007B | 18.74% | 121.01M |
FQ3 2020 (Sep 2020) | -0.54 | -0.54 | 0.120577B | 21.56% | 120.58M |
FQ2 2020 (Jun 2020) | -0.27 | -0.27 | 0.110103B | 24.43% | 110.1M |
FQ4 Announce Date
10/01/2024 (Pre-Market)
Consensus EPS Estimates
0.18378
Consensus Revenue Estimates
0.249959558B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2025 (Oct 2025) | 0.15 | -- | 0.14235 | 0.15538 | 11 |
FQ3 2025 (Jul 2025) | 0.18 | -- | 0.17081 | 0.18646 | 10 |
FQ2 2025 (Jun 2025) | 0.2719 | -- | 0.2608 | 0.28872 | 8 |
FQ1 2025 (Mar 2025) | -0.105 | -- | -0.10803 | -0.1006 | 8 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2025 (Oct 2025) | 0.27B | -- | 0.26B | 0.27B | 10 |
FQ3 2025 (Jul 2025) | 0.26B | -- | 0.25B | 0.27B | 9 |
FQ2 2025 (Jun 2025) | 0.25B | -- | 0.25B | 0.27B | 9 |
FQ1 2025 (Mar 2025) | 0.23B | -- | 0.22B | 0.23B | 5 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
0
EPS # of Misses
8
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2022 (Mar 2022) | -0.7 | -0.7 | 100% | |
FQ4 2021 (Dec 2021) | -0.27 | -0.27 | 100% | |
FQ3 2021 (Sep 2021) | -0.09 | -0.09 | 100% | |
FQ2 2021 (Jun 2021) | -0.27 | -0.27 | 100% | |
FQ1 2021 (Mar 2021) | -0.42 | -0.42 | 100% | |
FQ4 2020 (Dec 2020) | -0.42 | -0.42 | 100% | |
FQ3 2020 (Sep 2020) | -0.54 | -0.54 | 100% | |
FQ2 2020 (Jun 2020) | -0.27 | -0.27 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2022 (Mar 2022) | $0B | $0.12B | $115.47M | 100% |
FQ4 2021 (Dec 2021) | $0B | $0.13B | $130.76M | 100% |
FQ3 2021 (Sep 2021) | $0B | $0.13B | $131.61M | 100% |
FQ2 2021 (Jun 2021) | $0B | $0.12B | $115.22M | 100% |
FQ1 2021 (Mar 2021) | $0B | $0.11B | $106.55M | 100% |
FQ4 2020 (Dec 2020) | $0B | $0.12B | $121.01M | 100% |
FQ3 2020 (Sep 2020) | $0B | $0.12B | $120.58M | 100% |
FQ2 2020 (Jun 2020) | $0B | $0.11B | $110.1M | 100% |